Skip to content

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Stryker logo
StrykerSYK
$137.35B-12.4%
CONMED logo
CONMEDCNMD
$1.92B-29.6%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$24.74B-12.7%
Enovis logo
EnovisENOV
$2.62B-25.8%
OrthoPediatrics logo
OrthoPediatricsKIDS
$392.34M-30.5%

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-26.6%
P/S1.3×-0.4×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s enterprise value?
Treace Medical Concepts, Inc. (TMCI) reported enterprise value of $148.61M in Q1 2026.
How has Treace Medical Concepts, Inc.'s enterprise value changed year-over-year?
Treace Medical Concepts, Inc.'s enterprise value decreased by 74.4% year-over-year, from $581.36M to $148.61M.
What is the long-term trend for Treace Medical Concepts, Inc.'s enterprise value?
Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s enterprise value has grown at a -30.8% compound annual growth rate (CAGR), from $945.52M to $217.26M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.